Health Care & Life Sciences » Pharmaceuticals | Daiichi Sankyo Co. Ltd.

Daiichi Sankyo Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,118,241
919,372
986,446
955,124
960,195
929,717
Cost of Goods Sold (COGS) incl. D&A
402,289
323,087
318,622
349,373
346,021
364,605
Gross Income
715,952
596,285
667,824
605,751
614,174
565,112
SG&A Expense
339,126
469,761
513,770
477,876
501,848
474,651
EBIT
376,826
126,524
154,054
127,875
112,326
90,461
Unusual Expense
21,725
53,923
32,992
37,854
40,180
14,127
Non Operating Income/Expense
14,712
8,775
1,256
1,408
8,771
8,073
Interest Expense
12,151
1,740
1,383
5,808
2,681
2,335
Pretax Income
99,775
79,936
122,388
87,626
81,021
85,831
Income Tax
46,417
36,369
41,989
40,309
21,210
7,591
Equity in Affiliates
-
-
-
162
-
-
Consolidated Net Income
53,358
43,567
80,399
47,479
59,811
93,422
Net Income
60,943
46,762
82,282
53,466
60,282
93,410
Net Income After Extraordinaries
60,943
228,595
82,282
53,466
60,282
93,410
Net Income Available to Common
60,943
322,119
82,282
53,466
60,282
93,409
EPS (Basic)
86.57
457.56
119.37
79.63
91.31
144.20
Basic Shares Outstanding
704
704
689
671
660
648
EPS (Diluted)
86.41
456.62
119.11
79.44
91.10
143.88
Diluted Shares Outstanding
705
705
691
673
662
649
EBITDA
428,312
168,547
198,360
175,248
159,006
136,630
Non-Operating Interest Income
3,427
1,225
1,740
2,009
2,465
3,866
Minority Interest Expense
7,585
3,195
1,883
5,987
471
12
Equity in Affiliates (Pretax)
1,426
925
287
-
320
105

About Daiichi Sankyo Co.

View Profile
Address
Daiichi Sankyo Head Office Bldg, A&B
Tokyo Tokyo 103
Japan
Employees -
Website http://www.daiichisankyo.co.jp
Updated 07/08/2019
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries.